Literature DB >> 26287846

Testosterone and "Age-Related Hypogonadism"--FDA Concerns.

Christine P Nguyen1, Mark S Hirsch, David Moeny, Suresh Kaul, Mohamed Mohamoud, Hylton V Joffe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26287846      PMCID: PMC8905399          DOI: 10.1056/NEJMp1506632

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  4 in total

Review 1.  ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males.

Authors:  C Wang; E Nieschlag; R Swerdloff; H M Behre; W J Hellstrom; L J Gooren; J M Kaufman; J-J Legros; B Lunenfeld; A Morales; J E Morley; C Schulman; I M Thompson; W Weidner; F C W Wu
Journal:  Int J Impot Res       Date:  2008-10-16       Impact factor: 2.896

2.  Re: Joint meeting for Bone, Reproductive and Urologic Drugs Advisory Committee (BRUDAC) and the Drug Safety and Risk Management Advisory Committee (DSARM AC), September 17, 2014.

Authors:  Allen D Seftel
Journal:  J Urol       Date:  2014-11-15       Impact factor: 7.450

3.  Longitudinal effects of aging on serum total and free testosterone levels in healthy men. Baltimore Longitudinal Study of Aging.

Authors:  S M Harman; E J Metter; J D Tobin; J Pearson; M R Blackman
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

4.  Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011.

Authors:  J Bradley Layton; Dongmei Li; Christoph R Meier; Julie L Sharpless; Til Stürmer; Susan S Jick; M Alan Brookhart
Journal:  J Clin Endocrinol Metab       Date:  2014-01-01       Impact factor: 5.958

  4 in total
  33 in total

1.  Testosterone Treatment and Sexual Function in Older Men With Low Testosterone Levels.

Authors:  Glenn R Cunningham; Alisa J Stephens-Shields; Raymond C Rosen; Christina Wang; Shalender Bhasin; Alvin M Matsumoto; J Kellogg Parsons; Thomas M Gill; Mark E Molitch; John T Farrar; David Cella; Elizabeth Barrett-Connor; Jane A Cauley; Denise Cifelli; Jill P Crandall; Kristine E Ensrud; Laura Gallagher; Bret Zeldow; Cora E Lewis; Marco Pahor; Ronald S Swerdloff; Xiaoling Hou; Stephen Anton; Shehzad Basaria; Susan J Diem; Vafa Tabatabaie; Susan S Ellenberg; Peter J Snyder
Journal:  J Clin Endocrinol Metab       Date:  2016-06-29       Impact factor: 5.958

Review 2.  Sex Hormones and Sex Chromosomes Cause Sex Differences in the Development of Cardiovascular Diseases.

Authors:  Arthur P Arnold; Lisa A Cassis; Mansoureh Eghbali; Karen Reue; Kathryn Sandberg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-03-09       Impact factor: 8.311

3.  Age and duration of testosterone therapy predict time to return of sperm count after human chorionic gonadotropin therapy.

Authors:  Taylor P Kohn; Matthew R Louis; Stephen M Pickett; Mark C Lindgren; Jaden R Kohn; Alexander W Pastuszak; Larry I Lipshultz
Journal:  Fertil Steril       Date:  2016-11-14       Impact factor: 7.329

Review 4.  Testosterone therapy improves erectile function and libido in hypogonadal men.

Authors:  Paul J Rizk; Taylor P Kohn; Alexander W Pastuszak; Mohit Khera
Journal:  Curr Opin Urol       Date:  2017-11       Impact factor: 2.309

Review 5.  Androgens, aging, and prostate health.

Authors:  Karin Welén; Jan-Erik Damber
Journal:  Rev Endocr Metab Disord       Date:  2022-06-24       Impact factor: 6.514

Review 6.  Testosterone Replacement Therapy in Hypogonadal Men.

Authors:  Christina Wang; Ronald S Swerdloff
Journal:  Endocrinol Metab Clin North Am       Date:  2022-02-08       Impact factor: 4.741

7.  Dose-Response Relationships Between Gonadal Steroids and Bone, Body Composition, and Sexual Function in Aging Men.

Authors:  Joel S Finkelstein; Hang Lee; Sherri-Ann M Burnett-Bowie; Karin Darakananda; Emily C Gentile; David W Goldstein; Sarah H Prizand; Laura M Krivicich; Alexander P Taylor; Kendra E Wulczyn; Benjamin Z Leder; Elaine W Yu
Journal:  J Clin Endocrinol Metab       Date:  2020-08-01       Impact factor: 5.958

Review 8.  Testosterone replacement therapy and cardiovascular risk.

Authors:  Thiago Gagliano-Jucá; Shehzad Basaria
Journal:  Nat Rev Cardiol       Date:  2019-09       Impact factor: 32.419

Review 9.  Testosterone replacement in aging men: an evidence-based patient-centric perspective.

Authors:  Shalender Bhasin
Journal:  J Clin Invest       Date:  2021-02-15       Impact factor: 14.808

10.  Testosterone Therapy for the Treatment of Age-Related Hypogonadism: Risks with Uncertain Benefits.

Authors:  Christine P Nguyen; Mark Hirsch; Suresh Kaul; Corinne Woods; Hylton V Joffe
Journal:  Androg Clin Res Ther       Date:  2021-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.